Willis, O. (2021, October 19). The pandemic won’t end with a bang, but more likely a fizzle. Here’s how. ABC News. https://www.abc.net.au/news/health/2021-10-20/covid-19-pandemic-when-does-it-end-become-endemic-like-flu/100549816

Pearson, C. (2021, September 27). New Study Finds A Huge Perk Of Getting Vaccinated After Having COVID-19. HuffPost UK. https://www.huffpost.com/entry/study-covid-vaccine_l_6151dbbde4b098483a792e18

https://twitter.com/GYamey/status/1453132196416524292?s=20&t=REKS2qu5Ti7lby2jmu6Imw

Beaumont, P. (2021, December 17). T-cells in Pfizer Covid jab recipients stay robust against severe illness. The Guardian. https://www.theguardian.com/world/2021/dec/17/t-cells-pfizer-covid-jab-robust-against-severe-illness-south-africa-research

Bar-On, Y. M., Goldberg, Y., Mandel, M., Bodenheimer, O., Freedman, L., Alroy-Preis, S., Ash, N., Huppert, A., & Milo, R. (2021). Protection Across Age Groups of BNT162b2 Vaccine Booster against Covid-19 (p. 2021.10.07.21264626). https://doi.org/10.1101/2021.10.07.21264626

Marsh, S. (2021, December 1). Severe Covid infection doubles chances of dying in following year, study finds. The Guardian. https://www.theguardian.com/world/2021/dec/01/severe-covid-infection-doubles-chances-of-dying-in-following-year-study

Covid-19: Efficacité vaccinale. (2021, October 11). EPI-PHARE. https://www.epi-phare.fr/rapports-detudes-et-publications/impact-vaccination-covid-octobre-2021/

Morris, J. (2021, August 17). Israeli data: How can efficacy vs. severe disease be strong when 60% of hospitalized are vaccinated? Covid Data Science. https://www.covid-datascience.com/post/israeli-data-how-can-efficacy-vs-severe-disease-be-strong-when-60-of-hospitalized-are-vaccinated

Carl T. Bergstrom. (2021, August 18). 1. There has been lots of talk about recent data from Israel that seem to suggest a decline in vaccine efficacy against severe disease due to Delta, waning protection, or both. This may have even been a motivation for Biden’s announcement that the US would be adopting boosters. [Tweet]. @CT_Bergstrom. https://twitter.com/CT_Bergstrom/status/1427767356600688646

Lehnen, N., Glasauer, S., Schröder, L., Regnath, F., Biersack, K., Bergh, O. V. den, & Werder, D. von. (2022). Post-COVID symptoms in the absence of organic deficit—Lessons from diseases we know. PsyArXiv. https://doi.org/10.31234/osf.io/yqar2

Yonker, L. M., Boucau, J., Regan, J., Choudhary, M. C., Burns, M. D., Young, N., Farkas, E. J., Davis, J. P., Moschovis, P. P., Bernard Kinane, T., Fasano, A., Neilan, A. M., Li, J. Z., & Barczak, A. K. (2021). Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children. The Journal of Infectious Diseases, 224(11), 1821–1829. https://doi.org/10.1093/infdis/jiab509

Magee, L. A., Dadelszen, P. von, Kalafat, E., Duncan, E. L., O’Brien, P., Morris, E., Heath, P., & Khalil, A. (2021). COVID-19 vaccination in pregnancy—Number needed to vaccinate to avoid harm. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00691-5

Aufrichtig, A., & Walker, A. S. (2021, October 28). Who Had Covid-19 Vaccine Breakthrough Cases? The New York Times. https://www.nytimes.com/interactive/2021/10/28/us/covid-breakthrough-cases.html

ICMR drops Ivermectin, Hydroxychloroquine drugs from Covid treatment. (2021, September 24). The Times of India. https://timesofindia.indiatimes.com/india/icmr-drops-ivermectin-hydroxychloroquine-drugs-from-covid-treatment/articleshow/86475906.cms?__twitter_impression=true

Study finds no increased risk of COVID-19 vaccination in pregnancy. (n.d.). Retrieved October 4, 2021, from https://www.gavi.org/vaccineswork/study-finds-no-increased-risk-covid-19-vaccination-pregnancy

Mahase, E. (2021). Covid-19: Booster dose reduces infections and severe illness in over 60s, Israeli study reports. BMJ, 374, n2297. https://doi.org/10.1136/bmj.n2297

Kozlov, Max. ‘COVID-Vaccine Booster Shot Shows Promise in Israeli Study’. Nature, 16 September 2021. https://doi.org/10.1038/d41586-021-02516-4.

The BMJ. ‘Does the FDA Think These Data Justify the First Full Approval of a Covid-19 Vaccine?’, 23 August 2021. https://blogs.bmj.com/bmj/2021/08/23/does-the-fda-think-these-data-justify-the-first-full-approval-of-a-covid-19-vaccine/.

Carstensen, L. L., Shavit, Y. Z., & Barnes, J. T. (2020). Age Advantages in Emotional Experience Persist Even Under Threat From the COVID-19 Pandemic. Psychological Science, 31(11), 1374–1385. https://doi.org/10.1177/0956797620967261

Remmel, A. (2021). COVID vaccines and safety: What the research says. Nature, 590(7847), 538–540. https://doi.org/10.1038/d41586-021-00290-x

Garcia-Beltran et al showed that severely ill patients had the highest levels of antibodies. Anti-RBD IgG neutralisation was reduced in severely ill patients. The authors developed an antibody neutralisation potency index to indicate patients more likely to develop severe disease.

Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, et al. COVID-19-neutralizing antibodies predict disease severity and survival. Cell. 2021;184(2):476-88.e11.

MRC Centre for Global Infectious Disease Analysis on Twitter. (n.d.). Twitter. Retrieved 5 March 2021, from https://twitter.com/MRC_Outbreak/status/1331677485122121732

editor, Ian Sample Science. ‘Coronavirus: UK Scientists Identify Drugs That May Help Severe Cases’. The Guardian, 11 December 2020, sec. Science. https://www.theguardian.com/science/2020/dec/11/coronavirus-uk-scientists-identify-drugs-that-may-help-severe-cases.

Meeting the psychological needs of people recovering from severe coronavirus. (2020, May 7). https://www.youtube.com/watch?v=6hAUUTdhHlc&feature=youtu.be

Petersen, E., Koopmans, M., Go, U., Hamer, D. H., Petrosillo, N., Castelli, F., Storgaard, M., Khalili, S. A., & Simonsen, L. (2020). Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30484-9

Su, Q., Hu, J., Lin, H., Zhang, Z., Zhu, E. C., Zhang, C., Wang, D., Gao, Z., & Cao, B. (2020). Prevalence and risks of severe events for cancer patients with COVID-19 infection: A systematic review and meta-analysis. MedRxiv, 2020.06.23.20136200. https://doi.org/10.1101/2020.06.23.20136200